NATILE, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 15.317
EU - Europa 2.493
AS - Asia 1.467
OC - Oceania 14
SA - Sud America 9
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 4
Totale 19.308
Nazione #
US - Stati Uniti d'America 15.307
CN - Cina 1.319
SE - Svezia 796
UA - Ucraina 425
DE - Germania 309
FI - Finlandia 297
IT - Italia 296
GB - Regno Unito 185
SG - Singapore 60
IN - India 46
BE - Belgio 43
FR - Francia 42
IE - Irlanda 34
CZ - Repubblica Ceca 17
IR - Iran 15
AU - Australia 14
AT - Austria 10
NL - Olanda 8
CA - Canada 7
RU - Federazione Russa 6
VN - Vietnam 5
JP - Giappone 4
AE - Emirati Arabi Uniti 3
BR - Brasile 3
EU - Europa 3
HK - Hong Kong 3
HR - Croazia 3
HU - Ungheria 3
PL - Polonia 3
PT - Portogallo 3
BG - Bulgaria 2
CO - Colombia 2
ES - Italia 2
MY - Malesia 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BD - Bangladesh 1
BO - Bolivia 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
GL - Groenlandia 1
GR - Grecia 1
IL - Israele 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MM - Myanmar 1
MX - Messico 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
PR - Porto Rico 1
RO - Romania 1
SA - Arabia Saudita 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 19.308
Città #
Fairfield 2.572
Woodbridge 1.713
Chandler 1.288
Houston 1.161
Ashburn 1.153
Seattle 1.042
Jacksonville 979
Cambridge 882
Wilmington 781
Nyköping 656
Ann Arbor 615
Nanjing 356
Lawrence 288
Roxbury 284
Boardman 200
New York 193
Princeton 186
Des Moines 174
Beijing 173
Bari 152
San Diego 105
Nanchang 103
Dearborn 101
Inglewood 98
Brooklyn 91
Shenyang 84
Jiaxing 74
Hebei 73
Helsinki 52
Tianjin 49
Brussels 43
Los Angeles 38
Kunming 37
Changsha 33
Singapore 33
Dublin 32
Jinan 31
London 29
Pune 27
Shanghai 27
Guangzhou 24
Paris 24
San Mateo 22
Wuhan 21
Zhengzhou 21
Washington 20
Norwalk 17
Brno 16
Ardabil 13
Leawood 13
Ningbo 12
Lanzhou 11
Monmouth Junction 11
Falls Church 10
Hefei 10
Taizhou 10
Augusta 9
Mumbai 9
Auburn Hills 8
Melbourne 8
Munich 8
San Francisco 8
Hangzhou 7
Innsbruck 7
Marseille 7
Prescot 7
Wuxi 7
Changchun 6
Chicago 5
Molfetta 5
Noci 5
Noicattaro 5
Padova 5
Yiwu 5
Adelfia 4
Chiswick 4
Dong Ket 4
Edinburgh 4
Fuzhou 4
Kilburn 4
Milan 4
Quanzhou 4
Redmond 4
Redwood City 4
Shaoxing 4
Tappahannock 4
Toronto 4
Acton 3
Budapest 3
Grafing 3
Jinhua 3
Lisbon 3
Rio de Janeiro 3
Rome 3
Sassari 3
Shenzhen 3
Sydney 3
Tokyo 3
Wandsworth 3
Amsterdam 2
Totale 16.474
Nome #
Anticancer potential of a photoactivated transplatin derivative containing the methylazaindole ligand mediated by ROS generation and DNA cleavage 155
Anticancer kiteplatin pyrophosphate derivatives show unexpected target selectivity for DNA 124
A Pt(IV) prodrug of kiteplatin with the bone-targeting pyrophosphate ligand 122
Mechanistic and structural basis for inhibition of copper trafficking by platinum anticancer drugs 120
Amyloid Transition of Ubiquitin on Silver Nanoparticles Produced by Pulsed Laser Ablation in Liquid as a Function of Stabilizer and Single-Point Mutations 118
Bisphosphonate complexation and calcium doping in silica xerogels as a combined strategy for local and controlled release of active platinum antitumor compounds 115
Addition versus substitution in the reaction of diiodo(2,9-dimethyl-1,10-phenanthroline)platinum(II) with aromatic bases. X-ray crystal structures of the substitution products with 2-amino-pyridine and 1-methyl-cytosine 111
Cytotoxicity-boosting of kiteplatin by Pt(IV) prodrugs with axial benzoate ligands 111
Lantern-Shaped” Platinum(III) Complexes with Axially Bound 9-Ethylguanine or 1-Methylcytosine (L) of General Formula [Pt2{HN=C(But)O}4L2](NO3)2 110
A new case of polymorphism in platinum(II) complexes: [PtBr2(2,9-dimethyl-1,10-phenanthroline)]? 109
Addition of Hydroxide, Alkoxide, and Carboxylate Anions to Platinum-bonded Ethylene 108
Encapsulation of lipophilic kiteplatin Pt(IV) prodrugs in PLGA-PEG micelles 108
Effect of chirality in platinum drugs 106
Synthesis and X-ray Structural Characterization of Two Unbridged Diplatinum(III) Compounds: cis- and trans-Bis[bis(1-imino-1-methoxyethane)trichloroplatinum(III)]. Transient Species in the Oxidation of Platinum(II) to Platinum(IV) 105
Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs 105
null 104
Activation of Ketones by Electrophilic Metal Complexes. Synthesis of Some Ketonyl Platinum(II) Complexes and X-Ray Crystal Structure of [PtCl{CH2C(O)CH3}(1,10-phenanthroline)]·1/2Y (Y = H2O or CH2Cl2) 103
Activation of platinum(IV) prodrugs by cytochrome c and characterization of the protein binding sites 103
Chiral discrimination in the formation reaction and at equilibrium for N,N,N ',N '-tetramethyl-1,2-diaminocyclohexane-PtG(2) complexes 102
DNA fragment conformations in adducts with Kiteplatin 102
Isomerism of amides coordinated to platinum. X-ray crystal structure of dichloro-bisacetamide-platinum(II) 102
Insertion of terminal alkyne into Pt-N bond of the square planar [PtI2(Me2phen)] complex 101
Silver and gold nanoparticles produced by pulsed laser ablation in liquid to investigate their interaction with Ubiquitin 101
A new dinuclear platinum complex with a nitrogen-containing geminal bisphosphonate as potential anticancer compound specifically targeted to bone tissues 100
C hiral Discrimination in Platinum Anticancer Drugs 99
Dinuclear Pt(II)-bisphosphonate complexes: a scaffold for multinuclear or different oxidation state platinum drugs. 99
Dual-acting antitumor Pt(iv) prodrugs of kiteplatin with dichloroacetate axial ligands 99
Hydroxyapatite nanocrystals as a smart, pH sensitive, delivery system for kiteplatin 99
Copper binding to naturally occurring, lactam form of angiogenin differs from that to recombinant protein, affecting their activity 99
Dependence of the Reduction Products of Platinum(IV) Prodrugs upon the Configuration of the Substrate, Bulk of the Carrier Ligands, and Nature of the Reducing Agent 98
A model radiopharmaceutical agent targeted to translocator protein 18 kDa (TSPO) 98
Aggregation Pathways of Native-Like Ubiquitin Promoted by Single-Point Mutation, Metal Ion Concentration, and Dielectric Constant of the Medium 98
Synthesis, Characterization, and Cytotoxicity of the First Oxaliplatin Pt(IV) Derivative Having a TSPO Ligand in the Axial Position 97
Single-Stranded Oligonucleotide Adducts Formed by Pt Complexes Favoring Left-Handed Base Canting: Steric Effect of Flanking Residues and Relevance to DNA Adducts Formed by Pt Anticancer Drugs 96
A NMR, X-ray, and DFT combined study on the regio-chemistry of nucleophilic addition to platinum(II) coordinated terminal olefins 94
Cytotoxic trans-oriented platinum complexes only form adducts with single-stranded oligodeoxynucleotides 94
Computational metallomics of the anticancer drug cisplatin 94
Reactivity of kiteplatin with S-donor biomolecules and nucleotides 93
Structural biology of cisplatin complexes with cellular targets: the adduct with human copper chaperone Atox1 in aqueous solution 93
Synthesis and Characterization of Platinum(II) Complexes of Diethyl [(Methylsulfinyl)methyl]phosphonate: Potential Drugs against Bone Tumors 93
Platinum Complexes with the Novel Ligand Diethyl [(Methylsulfinyl)- methyl]phosphonate (SMP): Solid-State Characterization of Potassium Trichloro(SMP)platinum(II) which, in Solution, Gives Dichloro(SMP)- platinum(II) and Potassium Chloride 93
Reaction of Histone H1 with trans-Platinum Complexes and the Effect on DNA Platination 93
Trans-Platinum Compounds in Cancer Therapy: A largely Unexplored Strategy for Identifying Novel Antitumor Platinum Drugs 92
Cationic intermediates in oxidative addition reactions of Cl2 to [PtCl2(cis-1,4-DACH)] 92
Atropisomerization of cis-Bis(5'GMP)-Platinum(II)-Diamine complexes with Non-C2-symmetrical asymmetric diamine ligands containing NH groups directed to one side of the coordination plane 92
Novel Kiteplatin Pyrophosphate Derivatives with Improved Efficacy 92
Insights into the Molecular Mechanisms of Protein Platination from a Case Study: The Reaction of Anticancer Platinum(II) Iminoethers with Horse Heart Cytochrome c 91
Cytotoxic trans-oriented iminoether platinum complexes – Kinetics of binding to DNA oligonucleotides determined by 15N NMR spectroscopy 91
Synthesis, characterization, and cytotoxicity of dinuclear platinum-bisphosphonate complexes to be used as prodrugs in the local treatment of bone tumours 91
A General Procedure for the Selective Oxidation of Sulfides to Sulfoxides by Nitric Acid: Tetrabromoaurate(III) Catalyst in a Biphasic System 90
Chemical and cellular investigations of trans-ammine-pyridine-dichlorido-platinum(II), the likely metabolite of the antitumor active cis-diammine-pyridine-chorido-platinum(II) 90
Potentiation of cytotoxic action of cis-[PtCl2(NH3)(1M7AI)] by UVA irradiation. Mechanistic insights 90
X-ray structure and circular dichroism of pure rotamers of Bis[Guanosine-5'-monophosphate(-1)](N,N,N',N'-tetramethylcyclohexyl-1,2-diamine)platinum(II) complexes that have R,R and S,S configurations at the asymmetric diamine 89
A Seven-Membered Platinum-Amino-Amidine Metallacycle. X-ray Structure of cis-[Pt(NH=CPhNButCH2CH2NHBut)Cl2].´Me2CO 89
null 89
Conformer distribution in (cis-1,4-DACH)bis(guanosine5'-phosphate)platinum(II) adducts: a reliable model for DNA adducts of antitumoral cisplatin 89
The First Example of a Dinuclear Platinum(III) Complex with Three Bridging Ligands 88
NMR and X-ray Structural Characterization of a Cisplatin Analogue Able To Slow Down the Pt−N7 Rotation of a Coordinated Guanine Base by a Billion-Fold Times: 2,2'-Bipiperidine(dimethylmalonato)platinum(II) Complex 88
Cytotoxicity, mutagenicity, cellular uptake, DNA and glutathione interactions of lipophilic trans-platinum complexes tethered to 1-adamantylamine 88
Translocation of Platinum Anticancer Drugs by Human Copper ATPases ATP7A and ATP7B 88
Platinum amides from platinum nitriles: X-ray crystal structure of trans-dichloro-bis(1-imino-1-hydroxy-2,2-dimethylpropane)platinum(II) 88
null 88
NMR and X-ray characterization of a platinum(II) complex with (−)sparteine 88
Antitumor trans-platinum DNA adducts: NMR and HPLC study of the interaction between a trans-Pt(iminoether) complex and the deoxy decamer d(CCTCGCTCTC).d(GAGAGCGAGG) 87
The reaction of a platinated methionine motif of CTR1 with cysteine and histidine is dependent upon the type of precursor platinum complex 87
Copper Homeostasis in Humans and Bacteria 87
Cisplatin reacts with histone H1 and the adduct forms a ternary complex with DNA 87
Synthesis and characterization of a platinum(II) complex tethered to a ligand of the peripheral benzodiazepine receptor 86
The unexpected reactivity of Zeise's anion in strong basic medium discloses new substitution patterns at the platinum centre 85
Recognition of major DNA adducts of enantiomeric cisplatin analogs by HMG Box Proteins and Nucleotide Excision Repair of these adducts 84
Structural Determinants of Cisplatin and Transplatin Binding to the Met-Rich Motif of Ctr1: A Computational Spectroscopy Approach 84
Contribution of H-Bonding to the Preference of Platinum Anti-Tumour Drugs for Particular Bases and Particular Cross-Links 82
Synthesis and structural characterization of platinum(II)-acyclovir complexes 82
Role of metal ions and hydrogen bond acceptors in the tautomeric equilibrium of nitro-9[(alkylamino)amino]-acridine drugs 82
Conformational Selection of Ubiquitin Quaternary Structures Driven by Zinc Ions 82
Mono- and bis-guanosine adducts of platinum complexes with carrier ligands having in-plane steric bulk: The case of 1,10-phenanthroline and 2,9-dimethyl-1,10-phenanthroline 82
Antiviral properties and cytotoxic activity of platinum(II) complexes with 1,10-phenanthrolines and acyclovir or penciclovir 81
Fourier transform infrared spectroscopy Part V. Vibrational studies on phenanthroline-perchloric acid complexes 80
Synthesis and characterisation of the amidine complexes trans-[PtCl(NH3){HN=C(NH2)R}2]Cl (R = Me, Ph, CH2Ph) derived from addition of NH3 to the coordinated nitriles in trans-[PtCl2(NCR)2] 80
Five-coordinate alkene complexes of palladium(II) and platinum(II) 80
Unusual reactivity at a platinum center determined by the ligands and the solvent environment 80
Influence of steric and electronic factors in the stabilization of five-coordinate ethylene complexes of platinum(II): X-ray crystal structure of [PtCl2(2,9-dimethyl-1,10-phenanthroline-5,6-dione)] 80
Synthesis and structural characterization of isomeric "lantern-shaped" platinum(III) complexes of formula [Pt2(PPh3)X{N(H)C(R)O}4](NO3)2 (X=PPh3, H2O) 80
Platinum(II) complexes with the diethyl(aminomethyl)phosphonate ligand (amp): characterization, properties and unusual solution behavior 80
null 80
null 80
A new polymorph of dichlorido(1,10-phenanthroline)platinum(II) 79
Endocyclic versus exocyclic N-coordination to platinum(II) of some nitro-9-[(2-dialkylaminoethyl)amino]acridines 79
null 79
Biomimetic hydroxyapatite/drug nanocrystals as potential bone substitutes with anti-tumour drug delivery properties 78
Synthesis, characterization, and in vitro evaluation of a new TSPO-selective bifunctional chelate ligand 78
Solvolysis of Platinum Complexes with Substituted Ethylenediamines in Dimethylsulfoxide 78
Slowly Exchanging cis-PtA2B2 Atropisomers with A2 = Chiral DIamine Ligands and B = 5,6-Dimethylbenzimidazole 78
C60@Lysozyme: Direct Observation by Nuclear Magnetic Resonance of a 1:1 Fullerene Protein Adduct 78
Solution Behavior of Amidine Complexes: An Unexpected cis/trans Isomerization and Formation of Di- and Trinuclear Platinum(III) and Platinum(II) Species 77
Insertion of alkynes into Pt-X bonds of square planar [PtX2(N-N)] (X = Cl, Br, I) complexes 77
Unusual Interstrand Pt(S,S-diaminocyclohexane)-GG Crosslink Formed by Rearrangement of a Classical Intrastrand Crosslink Within a DNA Duplex 77
Five-Coordination in Platinum(II) and Palladium(II) Chemistry 77
Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance 77
H/D exchange at sp(3) carbons in the coordination sphere of platinum(II) 76
Totale 9.243
Categoria #
all - tutte 74.263
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.263


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.051 0 320 210 567 652 436 647 548 736 370 407 158
2020/20212.888 290 224 284 155 248 142 215 222 267 453 234 154
2021/20222.092 71 285 21 73 94 157 94 113 203 156 360 465
2022/20233.355 569 310 207 327 443 402 22 408 505 24 82 56
2023/20241.091 96 173 46 91 105 295 28 64 16 21 5 151
2024/2025222 176 46 0 0 0 0 0 0 0 0 0 0
Totale 19.731